257 related articles for article (PubMed ID: 28108813)
21. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
Kim HJ; Choi EH; Kil HR
J Korean Med Sci; 2014 Oct; 29(10):1385-90. PubMed ID: 25368492
[TBL] [Abstract][Full Text] [Related]
22. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
[TBL] [Abstract][Full Text] [Related]
23. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
[TBL] [Abstract][Full Text] [Related]
24. Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu D; Wang S; Yi H; Yang S
BMC Pediatr; 2019 Jan; 19(1):43. PubMed ID: 30704426
[TBL] [Abstract][Full Text] [Related]
25. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
26. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
[TBL] [Abstract][Full Text] [Related]
27. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
28. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y; Li H; Luo D; Jiang J; Liu B; Li G
Int Immunopharmacol; 2023 Sep; 122():110600. PubMed ID: 37423157
[TBL] [Abstract][Full Text] [Related]
29. [Recombinant human interleukin 35 (rhIL-35) alleviates the damage of coronary artery endothelial cells in Kawasaki disease by inhibiting NF-κB pathway].
Tian Z; Zhou Z; Yang Y; Li J; Hu L; Jiao R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Oct; 38(10):880-885. PubMed ID: 36163618
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic role of AIM2 in Kawasaki disease.
Wang Z; Wang Q; Jin J; Rong X; Wu T; Qiu H; Wu R
Clin Exp Med; 2021 Feb; 21(1):41-47. PubMed ID: 33079289
[TBL] [Abstract][Full Text] [Related]
31. The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease.
Wang QQ; Zheng LY; Zhao S
Turk J Pediatr; 2023; 65(4):640-649. PubMed ID: 37661679
[TBL] [Abstract][Full Text] [Related]
32. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
33. The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.
Zhang J; Weng H; Pei Q; Yang P; Fan W; Liu R; Yi Q
Clin Exp Med; 2022 Feb; 22(1):57-63. PubMed ID: 34232416
[TBL] [Abstract][Full Text] [Related]
34. Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease.
Chen Y; Yang M; Zhang M; Wang H; Zheng Y; Sun R; Li X
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):866-882. PubMed ID: 38357816
[TBL] [Abstract][Full Text] [Related]
35. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
Dominguez SR; Martin B; Heizer H; Jone PN; Tong S; Davidson J; Anderson MS; Glodé MP
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):297-302. PubMed ID: 26407256
[TBL] [Abstract][Full Text] [Related]
37. [Up-regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) of CD4⁺ T cells is positively related to RORC and IL-17A in patients with Kawasaki disease].
Wu S; Zhang X; Zhou N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Oct; 31(10):1378-82. PubMed ID: 26429539
[TBL] [Abstract][Full Text] [Related]
38. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
[TBL] [Abstract][Full Text] [Related]
39. Cytokines predict coronary aneurysm formation in Kawasaki disease patients.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1993 Apr; 152(4):309-12. PubMed ID: 8482278
[TBL] [Abstract][Full Text] [Related]
40. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
